首站-论文投稿智能助手
典型文献
Neutrophil-to-lymphocyte ratio or platelet-to-lymphocyte ratio is a predictive factor of pancreatic cancer patients with type 2 diabetes
文献摘要:
To the Editor: Pancreatic cancer(PC)is one of the most deadly cancers due to the difficulty of its early diagnosis.Most patients have developed an unresectable PC when diagnosed[1].According to GLOBOCAN 2018 estimates,PC ranked the 11th most common cancer in the world counting 458 918 new cases and causing 432 242 deaths(4.5%of all deaths caused by cancer)in 2018[2].
文献关键词:
作者姓名:
Bao Dong;Rong-Rong Wu
作者机构:
The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei 230031,China
引用格式:
[1]Bao Dong;Rong-Rong Wu-.Neutrophil-to-lymphocyte ratio or platelet-to-lymphocyte ratio is a predictive factor of pancreatic cancer patients with type 2 diabetes)[J].国际肝胆胰疾病杂志(英文版),2022(02):202-204
A类:
Pancreatic
B类:
Neutrophil,lymphocyte,ratio,platelet,predictive,pancreatic,patients,type,diabetes,To,Editor,one,most,deadly,cancers,due,difficulty,its,early,diagnosis,Most,have,developed,unresectable,when,diagnosed,According,GLOBOCAN,estimates,ranked,11th,common,world,counting,new,cases,causing,deaths,all,caused,by
AB值:
0.6508
相似文献
OShnscc:a novel user-friendly online survival analysis tool for head and neck squamous cell carcinoma based on RNA expression profiles and long-term survival information
Guosen ZHANG;Qiang WANG;Xinlei QI;Huimin YANG;Xiaodong SU;Manman YANG;Chao JIANG;Yang AN;Hong ZHENG;Lu ZHANG;Wan ZHU;Jiancheng GUO;Xiangqian GUO-Department of Predictive Medicine,Institute of Biomedical Informatics,Cell Signal Transduction Laboratory,Bioinformatics Center,Henan Provincial Engineering Center for Tumor Molecular Medicine,School of Basic Medical Sciences,Henan University,Kaifeng 475004,China;School of Software,Henan University,Kaifeng 475004,China;Department of Anesthesia,Stanford University,Stanford,CA 94305,USA;Department of Molecular Pathology,the Second Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;Precision Medicine Center,Academy of Medical Sciences,Zhengzhou University,Zhengzhou 450052,China;Henan Institute of Medical and Pharmaceutical Sciences,Zhengzhou University,Zhengzhou 450052,China
Sex disparity of lung cancer risk in non-smokers: a multicenter population-based prospective study based on China National Lung Cancer Screening Program
Wu Zheng;Tan Fengwei;Yang Zhuoyu;Wang Fei;Cao Wei;Qin Chao;Dong Xuesi;Zheng Yadi;Luo Zilin;Zhao Liang;Yu Yiwen;Xu Yongjie;Ren Jiansong;Shi Jufang;Chen Hongda;Li Jiang;Tang Wei;Shen Sipeng;Wu Ning;Chen Wanqing;Li Ni;He Jie-Office of Cancer Screening, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Key Laboratory of Cancer Data Science, Chinese Academy of Medical Sciences, Beijing 100021, China;Department of Thoracic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;PET-CT Center, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Department of Diagnostic Radiology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China
Binghe Xu;Huiping Li;Zefei Jiang;Lin Gu;Jinhai Tang;Hui Xie;Yueyin Pan;Yunjiang Liu;Shude Cui;Xiaojia Wang;Li Cai;Yiqiong Zhang;Huadong Zhao;Zhimin Shao-Department of Medical Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Breast Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Breast Cancer,the Fifth Medical Center of Chinese PLA General Hospital,Beijing 100071,China;Department of Breast Cancer,Tianjin Cancer Institute and Hospital,Tianjin 300060,China;Department of Breast Cancer,Jiangsu Provincial Hospital,Nanjing 210029,China;Department of Breast Cancer,the First Affiliated Hospital of China University of Science and Technology,Hefei 230001,China;Department of Breast Cancer,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,China;Department of Breast Cancer,Henan Cancer Hospital,Zhengzhou 450008,China;Department of Breast Cancer,Zhejiang Cancer Hospital,Hangzhou 310012,China;Department of Breast Cancer,Harbin Medical University Cancer Hospital,Harbin 150081,China;Department of Clinical Development,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Statistics,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Breast Surgery,Shanghai Cancer Center/Cancer Institute,Shanghai Medical College,Fudan University,Shanghai 200032,China
Chinese quality control indices for standardized diagnosis and treatment of gastric cancer (2022 edition)
Shen Li;Fei Shan;Xiaotian Zhang;Yongheng Li;Yu Sun;Lei Tang;Qi Wu;Wenjing Yang;Jincheng Yang;Yu An;Ming Deng;Jiafu Ji-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Gastrointestinal Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiotherapy,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Pathology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Endoscopy Center,Peking University Cancer Hospital&Institute,Beijing 100142,China;Office for Cancer Diagnosis and Treatment Quality Control,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。